Resolutions of Extraordinary General Meeting The Extraordinary General Meeting of AB Invalda (the “Company”) dated 21 November, 2005 resolved: 1. To increase Company’s authorized capital by LTL 1 317 323,..
MorePreliminary unaudited result for 9 months of 2005 The company‘s preliminary unaudited net profit for 9 months of 2005 – LTL 13.912 million (EUR 4.029 million). Profit before taxes for..
MoreInvalda AB Material Event 19-10-2005 Resolutions of the Board Meeting Resolutions of the Board of meeting of AB Invalda (the “Company”) dated 18 October 2005: 1. On 21 November 2005..
MoreSeeking to ensure the return of LTL 30 mln credit, the company mortgaged 1953135 units of Vilniaus baldai AB shares and 297000 units of Sanitas AB shares. Alvydas BanysVice-president+370 5..
MoreSeeking to ensure fulfilment of Vilniaus baldai AB credit agreement,the company mortgaged 15 % block of Vilniaus baldai AB shares to banks. Alvydas BanysVice-president+370 5 279 06 91
MoreThe company’s preliminary un-audited net profit, prepared according to IAS, for the first half of 2005 is LTL 5961558 (EUR 1726587) Alvydas BanysVice-president+370 5 279 06 91
MoreThe largest Lithuanian pharmaceutical company “Sanitas” took over the control of purchased Slovak pharmaceutical plant “Hoechst-Biotika” today. The purchase price is LTL 43.85 mln. “The settlement with the sellers of “Hoechst-Biotika” went..
MoreOn July 15 2005 after new issue of registered ordinary shares of AB Sanitas and increase of AB Sanitas share capital to 11 000 000 LTL, AB Invalda group has..
MoreAB “Invalda” Material Event Preliminary result for the first quarter of 2005 The company’s preliminary un-audited net profit for the first quarter of 2005 is LTL 1886160. Alvydas BanysVice-president+370 5..
More